Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Immatics US, Inc.
Acepodia Biotech, Inc.
BioEclipse Therapeutics
Fate Therapeutics
Fate Therapeutics
City of Hope Medical Center
Rutgers, The State University of New Jersey
Cancer Research UK